PMID: 6985612Jan 1, 1980Paper

Absence of fibronectin and presence of plasminogen activator in both normal and malignant human mammary epithelial cells in culture

The Journal of Cell Biology
N S YangP Furmanski

Abstract

Primary monolayer cultures of normal and malignant human mammary epithelial cells were tested for fibronectin by indirect immunofluorescence using antisera specific for fibronectin. This protein was not detectable on either the normal or malignant epithelial cells. Similar results were obtained for normal and malignant mouse mammary epithelial cell cultures. Control normal and transformed fibroblasts exhibited the expected result: the normal cells were positive and the transformed cells were negative. With the use of supernatant fluids from the same cultures or an agar-overlay assay on viable cells, high levels of plasminogen-dependent fibrinolytic activity were detectable in both the normal and malignant mammary cells. Thus, two characteristics that distinguish normal from transformed fibroblasts do not serve as markers of malignancy in mammary epithelial/carcinoma systems.

References

Jun 20, 1978·Annals of the New York Academy of Sciences·E A Jaffe, D F Mosher
Aug 17, 1978·Biochimica Et Biophysica Acta·V Mahdavi, R O Hynes
Oct 15, 1976·International Journal of Cancer. Journal International Du Cancer·B A Voyles, C M McGrath
Jul 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·C R BirdwellG L Nicolson
Jun 20, 1978·Annals of the New York Academy of Sciences·E LinderA Vaheri
Jan 24, 1977·Biochemical and Biophysical Research Communications·J Keski-OjaA Vaheri
Apr 1, 1978·The Journal of Experimental Medicine·S Stenman, A Vaheri
Sep 1, 1978·The Journal of Cell Biology·E CrouchP Bornstein
Feb 1, 1979·Experimental Cell Research·C B Wigley, I C Summerhayes
Apr 30, 1976·Biochimica Et Biophysica Acta·R O Hynes
Apr 1, 1977·Experimental Cell Research·L B ChenJ K McDougall
Apr 25, 1977·Biochemical and Biophysical Research Communications·N MarceauD Mailhot
Jul 15, 1975·International Journal of Cancer. Journal International Du Cancer·W A Nelson-ReesP K Hawthorne
Oct 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·L B ChenJ K McDougall
Feb 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·N M Hogg
Sep 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·K M Yamada, J A Weston
Apr 1, 1971·Proceedings of the Society for Experimental Biology and Medicine·W D PetersonW F Simpson

❮ Previous
Next ❯

Citations

Jan 1, 1985·Journal of Cancer Research and Clinical Oncology·E W Gabrielson, C C Harris
Jan 1, 1984·Virchows Archiv. A, Pathological Anatomy and Histopathology·P G NataliC De Martino
Jan 1, 1985·Virchows Archiv. A, Pathological Anatomy and Histopathology·L ChristensenI Clemmensen
Jan 1, 1985·Journal of Cancer Research and Clinical Oncology·D Lorke, P Möller
Mar 1, 1983·Developmental Biology·E J OrmerodP S Rudland
Mar 25, 2006·Nature Reviews. Cancer·Tetsuo KondoSylvia L Asa
Jun 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·A G BrownellH C Slavkin
Jul 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·E G Fey, S Penman
Dec 1, 1981·The Journal of Cell Biology·M J WarburtonP S Rudland
Jul 1, 1983·Journal of Clinical Pathology·A J D'ArdenneM K Bennett
Feb 1, 1986·Journal of Clinical Pathology·A J d'ArdenneJ D Davies
Aug 1, 1983·European Journal of Cancer & Clinical Oncology·M L TenchiniL De Carli
Jul 1, 1981·Experimental Cell Research·A BenedettoM G Santoro
Apr 1, 1984·The Journal of Pathology·A J D'Ardenne, J O McGee
Oct 15, 1980·International Journal of Cancer. Journal International Du Cancer·C J Der, E J Stanbridge
Mar 15, 1985·European Journal of Biochemistry·A Electricwala, T Atkinson
Jan 1, 1981·International Journal of Cancer. Journal International Du Cancer·S Stenman, A Vaheri
Feb 15, 1985·International Journal of Cancer. Journal International Du Cancer·B EdelmanV Defendi
Jan 1, 1985·Biochimica Et Biophysica Acta·J M Vasiliev
Jan 1, 1985·Biochimica Et Biophysica Acta·A Ben-Ze'ev
Nov 12, 1985·Biochimica Et Biophysica Acta·O Saksela
Feb 1, 1982·European Journal of Cancer & Clinical Oncology·T Thorsen
Dec 1, 1983·The Journal of Investigative Dermatology·R A Clark
Jun 1, 1984·The Journal of Investigative Dermatology·M KuboR A Clark
Apr 1, 1983·The Journal of Investigative Dermatology·R R IsseroffD B Rifkin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Virchows Archiv. B, Cell Pathology Including Molecular Pathology
M A GibertM Pavans de Ceccatty
Journal of Supramolecular Structure
L B ChenP H Gallimore
International Journal of Cancer. Journal International Du Cancer
S Stenman, A Vaheri
© 2021 Meta ULC. All rights reserved